Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research Image Cannabis News September 25, 2024 Enveric Biosciences has presented research highlighting the its lead compound, EB-003 at the 7th Neuropsychiatric Drug Summit. Psychedelics biotech company Enveric Biosciences ENVB has presented research highlighting its lead compound, EB-003 at the 7th Neuropsychiatric Drug Summit showing Marijuana Business News by Jelena Martinovic